ID: ALA1830616

Max Phase: Preclinical

Molecular Formula: C35H28F3N5O

Molecular Weight: 591.64

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ccc(C(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)cc1

Standard InChI:  InChI=1S/C35H28F3N5O/c36-35(37,38)33-22-32(26-9-16-31-25(21-26)6-5-23-3-1-2-4-30(23)31)43(40-33)29-14-12-28(13-15-29)41-17-19-42(20-18-41)34(44)24-7-10-27(39)11-8-24/h1-16,21-22H,17-20,39H2

Standard InChI Key:  JJBJZFCUKCRTPL-UHFFFAOYSA-N

Associated Targets(Human)

3-phosphoinositide dependent protein kinase-2, PDK2 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDPK1 Tchem 3-phosphoinositide dependent protein kinase-1 (3758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 591.64Molecular Weight (Monoisotopic): 591.2246AlogP: 7.41#Rotatable Bonds: 4
Polar Surface Area: 67.39Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.17CX LogP: 7.08CX LogD: 7.08
Aromatic Rings: 6Heavy Atoms: 44QED Weighted: 0.17Np Likeness Score: -1.08

References

1. Lee SL, Hsu EC, Chou CC, Chuang HC, Bai LY, Kulp SK, Chen CS..  (2011)  Identification and characterization of a novel integrin-linked kinase inhibitor.,  54  (18): [PMID:21823616] [10.1021/jm2007744]

Source